Search results
View Huixia Zhang’s profile on LinkedIn, a professional community of 1 billion members. clinical pharmacologist at FDA · Experience: FDA · Location: Rockville · 170 connections on LinkedIn.
- 170
- FDA
- Juxian yi zhong
- Rockville, Maryland, United States
Huixia ZHANG, Taipa, Macau, China | Cited by 205 | of Macau University of Science and Technology, Macau (MUST) | Read 19 publications | Contact Huixia ZHANG
Macau University of Science and Technology - Cited by 199 - RNA modification
View huixia zhang’s profile on LinkedIn, the world’s largest professional community. huixia has 2 jobs listed on their profile.
- AstraZeneca
- Gaithersburg, Maryland, United States
- Director, Clinical Pharmacology
Mar 31, 2024 · Abstract. The activation of YAP/TAZ, a pair of paralogs of transcriptional coactivators, initiates a dysregulated transcription program, which is a key feature of human cancer cells. However, it is not fully understood how YAP/TAZ promote dysregulated transcription for tumor progression.
Mar 31, 2024 · In a genetically engineered lung adenocarcinoma mouse model and non-small cell lung cancer patients, SRCAP complex and H2A.Z deposition were found to be upregulated. This upregulation was statistically correlated with YAP expression, pathological stages, and poor survival in lung cancer patients.
Huixia Zhang received the B.S. degree in measurement and control technology and instrumentation from the Hebei University of Science and Technology, Shijiazhuang, China, in 2015, and the M.S. degree in control theory and control engineering from Yanshan University, Qinhuangdao, China, in 2019.
